References Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical Programme, 16 September 2025, Novo Nordisk, DAscanio AM, Mullally JA, Frishman WH
Other known interactions include barbiturates, fosphenytoin (Cerebyx, Sesquient), phenytoin (Dilantin, Phenytek), and Levodopa
J.TurnbullD
A simple misstep here can compromise your entire experiment, leading to wasted time, resources, and potentially skewed data
It can enhance wound healing by supporting cell proliferation and tissue repair
According to the applicant, the Axoguard HA+ Nerve Protector TM is designed to be a protective interface between the nerve and the surrounding tissue to minimize the potential for soft tissue attachments and tethering that restricts the nerve's ability to glide and move through the tissue structures during anatomic movement